AlphaMark Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

AlphaMark Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$10K	Hold	150	–	–	﹤0.01%	449
2024 Q3	$11K	Hold	150	–	–	﹤0.01%	503
2024 Q2	$10K	Hold	150	–	–	﹤0.01%	530
2024 Q1	$10K	Hold	150	–	–	﹤0.01%	535
2023 Q4	$9K	Hold	150	–	–	﹤0.01%	539
2023 Q3	$9K	Hold	150	–	–	﹤0.01%	532
2023 Q2	$9K	Hold	150	–	–	﹤0.01%	422
2023 Q1	$9K	Hold	150	–	–	﹤0.01%	424
2022 Q4	$9K	Hold	150	–	–	﹤0.01%	387
2022 Q3	$8K	Hold	150	–	–	﹤0.01%	447
2022 Q2	$10K	Hold	150	–	–	﹤0.01%	396
2022 Q1	$10K	Hold	150	–	–	﹤0.01%	402
2021 Q4	$10K	Hold	150	–	–	﹤0.01%	393
2021 Q3	$9K	Hold	150	–	–	﹤0.01%	414
2021 Q2	$9K	Hold	150	–	–	﹤0.01%	410
2021 Q1	$9K	Hold	150	–	–	﹤0.01%	399
2020 Q4	$9K	Hold	150	–	–	﹤0.01%	378
2020 Q3	$8K	Hold	150	–	–	﹤0.01%	386
2020 Q2	$8K	Hold	150	–	–	﹤0.01%	389
2020 Q1	$7K	Hold	150	–	–	﹤0.01%	345
2019 Q4	$8K	Hold	150	–	–	﹤0.01%	358
2019 Q3	$7K	Hold	150	–	–	﹤0.01%	366
2019 Q2	$8K	Hold	150	–	–	﹤0.01%	361
2019 Q1	$8K	Hold	150	–	–	﹤0.01%	346
2018 Q4	$7K	Hold	150	–	–	﹤0.01%	348
2018 Q3	$8K	Hold	150	–	–	﹤0.01%	371
2018 Q2	$8K	Hold	150	–	–	﹤0.01%	387
2018 Q1	$7K	Sell	150 -195	-57%	-$10K	﹤0.01%	388
2017 Q4	$18K	Hold	345	–	–	0.01%	293
2017 Q3	$18K	Hold	345	–	–	0.01%	288
2017 Q2	$18K	Hold	345	–	–	0.01%	282
2017 Q1	$17K	Hold	345	–	–	0.01%	279
2016 Q4	$16K	Hold	345	–	–	0.01%	270
2016 Q3	$17K	Buy	+345	New	+$17.5K	0.01%	213

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AlphaMark Advisors's IHE Position: Q4 2024 in Review

AlphaMark Advisors held its iShares US Pharmaceuticals ETF (IHE) position steady in Q4 2024 at 150 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

AlphaMark Advisors first reported a position in IHE in Q3 2016 and has held it in 34 quarters since. The position peaked at $18K in Q4 2017. 155 funds tracked by Wall St. Rank hold IHE as of Q4 2024.

AlphaMark Advisors held 150 shares of iShares US Pharmaceuticals ETF worth $10K as of Q4 2024.
AlphaMark Advisors left its iShares US Pharmaceuticals ETF share count unchanged in Q4 2024.
iShares US Pharmaceuticals ETF made up ﹤0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #449 holding.
AlphaMark Advisors first reported a position in iShares US Pharmaceuticals ETF in Q3 2016 and has held it in 34 quarters since.
AlphaMark Advisors's iShares US Pharmaceuticals ETF position peaked at $18K in Q4 2017.
155 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.